{"disease":{"id":"empagliflozin-in-post-aki-stage-2-3","name":"empagliflozin in post aki stage 2 3"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05360615","title":"The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":147,"lead_sponsor_name":"Chulalongkorn University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}